Is NAD+ with glutathione legal in Australia?

Usually two separate preparations given in one clinic visit rather than one vial, because no premixed product is canonical. NAD+ infusions raise blood NAD, which is a measurement rather than an outcome. The best controlled trial of intravenous glutathione, in Parkinson's disease, found no significant difference in symptom scores against placebo.

The drip clinic version of longevity. A typical visit is a hydration bag, a glutathione push and a NAD+ infusion, sometimes with B vitamins alongside.

Mechanism: NAD+ is a central redox cofactor and a substrate for sirtuins and PARPs; the rationale for raising it is that tissue NAD declines with age. Whether infused NAD+ enters cells intact or is degraded to precursors first is not settled, which is a real gap given that the oral evidence is all precursor evidence.

Regulatory history: Neither is an approved drug for these uses. Both are supplied as compounded injections, which are not FDA approved and are not reviewed for safety, effectiveness or quality.

Registers or lists therapeutic goods on the ARTG and schedules substances in the Poisons Standard. Many peptides are Schedule 4 (prescription only), so possession without a prescription and personal importation are restricted even when no product is registered.

The classification above is the The Longevity Archive reading of Therapeutic Goods Administration listings for NAD+ with glutathione at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.